nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CES1—Trandolapril—coronary artery disease	0.213	0.359	CbGbCtD
Capecitabine—CES1—Clopidogrel—coronary artery disease	0.195	0.328	CbGbCtD
Capecitabine—CYP2C9—Fenofibrate—coronary artery disease	0.0285	0.0481	CbGbCtD
Capecitabine—CYP2C9—Gemfibrozil—coronary artery disease	0.0228	0.0384	CbGbCtD
Capecitabine—CYP2C9—Clopidogrel—coronary artery disease	0.0197	0.0333	CbGbCtD
Capecitabine—CYP2C9—Pitavastatin—coronary artery disease	0.0173	0.0291	CbGbCtD
Capecitabine—CYP2C9—Valsartan—coronary artery disease	0.0168	0.0283	CbGbCtD
Capecitabine—CYP2C9—Rosuvastatin—coronary artery disease	0.0127	0.0215	CbGbCtD
Capecitabine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0124	0.0209	CbGbCtD
Capecitabine—CYP2C9—Simvastatin—coronary artery disease	0.0118	0.02	CbGbCtD
Capecitabine—CYP2C9—Lovastatin—coronary artery disease	0.0116	0.0195	CbGbCtD
Capecitabine—CYP2C9—Pravastatin—coronary artery disease	0.0116	0.0195	CbGbCtD
Capecitabine—CYP2C9—Atorvastatin—coronary artery disease	0.0105	0.0178	CbGbCtD
Capecitabine—CYP2C9—cardial valve—coronary artery disease	0.0097	0.242	CbGeAlD
Capecitabine—CYP2C9—Losartan—coronary artery disease	0.00964	0.0163	CbGbCtD
Capecitabine—DPYD—myocardium—coronary artery disease	0.00354	0.0884	CbGeAlD
Capecitabine—TYMP—endothelium—coronary artery disease	0.00328	0.082	CbGeAlD
Capecitabine—DPYD—heart—coronary artery disease	0.00247	0.0617	CbGeAlD
Capecitabine—CDA—heart—coronary artery disease	0.00238	0.0594	CbGeAlD
Capecitabine—TYMP—cardiac ventricle—coronary artery disease	0.00218	0.0544	CbGeAlD
Capecitabine—DPYD—cardiac atrium—coronary artery disease	0.00211	0.0528	CbGeAlD
Capecitabine—DPYD—blood—coronary artery disease	0.00184	0.046	CbGeAlD
Capecitabine—CDA—blood—coronary artery disease	0.00177	0.0443	CbGeAlD
Capecitabine—TYMP—heart—coronary artery disease	0.00143	0.0357	CbGeAlD
Capecitabine—TYMP—cardiovascular system—coronary artery disease	0.00135	0.0337	CbGeAlD
Capecitabine—CES1—heart—coronary artery disease	0.00124	0.0309	CbGeAlD
Capecitabine—TYMP—cardiac atrium—coronary artery disease	0.00122	0.0306	CbGeAlD
Capecitabine—CES1—cardiovascular system—coronary artery disease	0.00117	0.0291	CbGeAlD
Capecitabine—TYMP—blood—coronary artery disease	0.00107	0.0267	CbGeAlD
Capecitabine—CES1—blood—coronary artery disease	0.000922	0.023	CbGeAlD
Capecitabine—TYMS—blood—coronary artery disease	0.000916	0.0229	CbGeAlD
Capecitabine—TYMS—Fluvastatin—Pitavastatin—coronary artery disease	0.000658	0.175	CbGdCrCtD
Capecitabine—TYMS—Fluvastatin—Rosuvastatin—coronary artery disease	0.000587	0.156	CbGdCrCtD
Capecitabine—TYMS—Simvastatin—Pravastatin—coronary artery disease	0.000561	0.15	CbGdCrCtD
Capecitabine—TYMS—Simvastatin—Lovastatin—coronary artery disease	0.000561	0.15	CbGdCrCtD
Capecitabine—CYP2C9—heart—coronary artery disease	0.000536	0.0134	CbGeAlD
Capecitabine—CYP2C9—cardiovascular system—coronary artery disease	0.000506	0.0126	CbGeAlD
Capecitabine—TYMS—Fluvastatin—Atorvastatin—coronary artery disease	0.000499	0.133	CbGdCrCtD
Capecitabine—TYMS—Pitavastatin—Rosuvastatin—coronary artery disease	0.000479	0.128	CbGdCrCtD
Capecitabine—TYMS—Pitavastatin—Atorvastatin—coronary artery disease	0.000407	0.108	CbGdCrCtD
Capecitabine—CYP2C9—blood—coronary artery disease	0.0004	0.00999	CbGeAlD
Capecitabine—Dermatitis—Ezetimibe—coronary artery disease	3.98e-05	0.000155	CcSEcCtD
Capecitabine—Confusional state—Ramipril—coronary artery disease	3.98e-05	0.000155	CcSEcCtD
Capecitabine—Discomfort—Timolol—coronary artery disease	3.98e-05	0.000155	CcSEcCtD
Capecitabine—Asthenia—Niacin—coronary artery disease	3.97e-05	0.000155	CcSEcCtD
Capecitabine—Fatigue—Losartan—coronary artery disease	3.97e-05	0.000155	CcSEcCtD
Capecitabine—Headache—Ezetimibe—coronary artery disease	3.96e-05	0.000154	CcSEcCtD
Capecitabine—Malaise—Lisinopril—coronary artery disease	3.96e-05	0.000154	CcSEcCtD
Capecitabine—Oedema—Ramipril—coronary artery disease	3.95e-05	0.000154	CcSEcCtD
Capecitabine—Vertigo—Lisinopril—coronary artery disease	3.94e-05	0.000154	CcSEcCtD
Capecitabine—Dry mouth—Timolol—coronary artery disease	3.94e-05	0.000154	CcSEcCtD
Capecitabine—Pain—Losartan—coronary artery disease	3.94e-05	0.000154	CcSEcCtD
Capecitabine—Constipation—Losartan—coronary artery disease	3.94e-05	0.000154	CcSEcCtD
Capecitabine—Syncope—Lisinopril—coronary artery disease	3.93e-05	0.000153	CcSEcCtD
Capecitabine—Vomiting—Eplerenone—coronary artery disease	3.93e-05	0.000153	CcSEcCtD
Capecitabine—Feeling abnormal—Furosemide—coronary artery disease	3.93e-05	0.000153	CcSEcCtD
Capecitabine—Leukopenia—Lisinopril—coronary artery disease	3.93e-05	0.000153	CcSEcCtD
Capecitabine—Nausea—Fenofibrate—coronary artery disease	3.92e-05	0.000153	CcSEcCtD
Capecitabine—Pruritus—Niacin—coronary artery disease	3.92e-05	0.000153	CcSEcCtD
Capecitabine—Asthenia—Pravastatin—coronary artery disease	3.91e-05	0.000153	CcSEcCtD
Capecitabine—Gastrointestinal pain—Furosemide—coronary artery disease	3.9e-05	0.000152	CcSEcCtD
Capecitabine—Rash—Eplerenone—coronary artery disease	3.9e-05	0.000152	CcSEcCtD
Capecitabine—Urticaria—Perindopril—coronary artery disease	3.9e-05	0.000152	CcSEcCtD
Capecitabine—Hypersensitivity—Trandolapril—coronary artery disease	3.9e-05	0.000152	CcSEcCtD
Capecitabine—Dermatitis—Eplerenone—coronary artery disease	3.9e-05	0.000152	CcSEcCtD
Capecitabine—Diarrhoea—Valsartan—coronary artery disease	3.89e-05	0.000152	CcSEcCtD
Capecitabine—Confusional state—Timolol—coronary artery disease	3.89e-05	0.000152	CcSEcCtD
Capecitabine—Shock—Ramipril—coronary artery disease	3.88e-05	0.000152	CcSEcCtD
Capecitabine—Hypersensitivity—Enalapril—coronary artery disease	3.88e-05	0.000152	CcSEcCtD
Capecitabine—Body temperature increased—Perindopril—coronary artery disease	3.88e-05	0.000151	CcSEcCtD
Capecitabine—Abdominal pain—Perindopril—coronary artery disease	3.88e-05	0.000151	CcSEcCtD
Capecitabine—Palpitations—Lisinopril—coronary artery disease	3.88e-05	0.000151	CcSEcCtD
Capecitabine—Diarrhoea—Olmesartan—coronary artery disease	3.88e-05	0.000151	CcSEcCtD
Capecitabine—Headache—Eplerenone—coronary artery disease	3.88e-05	0.000151	CcSEcCtD
Capecitabine—Nervous system disorder—Ramipril—coronary artery disease	3.87e-05	0.000151	CcSEcCtD
Capecitabine—Thrombocytopenia—Ramipril—coronary artery disease	3.86e-05	0.000151	CcSEcCtD
Capecitabine—Oedema—Timolol—coronary artery disease	3.86e-05	0.000151	CcSEcCtD
Capecitabine—Pruritus—Pravastatin—coronary artery disease	3.86e-05	0.00015	CcSEcCtD
Capecitabine—Loss of consciousness—Lisinopril—coronary artery disease	3.86e-05	0.00015	CcSEcCtD
Capecitabine—Nausea—Clopidogrel—coronary artery disease	3.85e-05	0.00015	CcSEcCtD
Capecitabine—Tachycardia—Ramipril—coronary artery disease	3.85e-05	0.00015	CcSEcCtD
Capecitabine—Skin disorder—Ramipril—coronary artery disease	3.83e-05	0.00015	CcSEcCtD
Capecitabine—Infection—Timolol—coronary artery disease	3.83e-05	0.00015	CcSEcCtD
Capecitabine—Vomiting—Simvastatin—coronary artery disease	3.83e-05	0.00015	CcSEcCtD
Capecitabine—Hypersensitivity—Telmisartan—coronary artery disease	3.83e-05	0.000149	CcSEcCtD
Capecitabine—Cough—Lisinopril—coronary artery disease	3.83e-05	0.000149	CcSEcCtD
Capecitabine—Nausea—Lovastatin—coronary artery disease	3.83e-05	0.000149	CcSEcCtD
Capecitabine—Hyperhidrosis—Ramipril—coronary artery disease	3.82e-05	0.000149	CcSEcCtD
Capecitabine—Rash—Simvastatin—coronary artery disease	3.8e-05	0.000148	CcSEcCtD
Capecitabine—Dermatitis—Simvastatin—coronary artery disease	3.8e-05	0.000148	CcSEcCtD
Capecitabine—Asthenia—Trandolapril—coronary artery disease	3.8e-05	0.000148	CcSEcCtD
Capecitabine—Shock—Timolol—coronary artery disease	3.8e-05	0.000148	CcSEcCtD
Capecitabine—Feeling abnormal—Losartan—coronary artery disease	3.79e-05	0.000148	CcSEcCtD
Capecitabine—Urticaria—Furosemide—coronary artery disease	3.79e-05	0.000148	CcSEcCtD
Capecitabine—Diarrhoea—Niacin—coronary artery disease	3.79e-05	0.000148	CcSEcCtD
Capecitabine—Nervous system disorder—Timolol—coronary artery disease	3.78e-05	0.000148	CcSEcCtD
Capecitabine—Asthenia—Enalapril—coronary artery disease	3.78e-05	0.000148	CcSEcCtD
Capecitabine—Headache—Simvastatin—coronary artery disease	3.78e-05	0.000147	CcSEcCtD
Capecitabine—Abdominal pain—Furosemide—coronary artery disease	3.77e-05	0.000147	CcSEcCtD
Capecitabine—Body temperature increased—Furosemide—coronary artery disease	3.77e-05	0.000147	CcSEcCtD
Capecitabine—Gastrointestinal pain—Losartan—coronary artery disease	3.76e-05	0.000147	CcSEcCtD
Capecitabine—Dizziness—Valsartan—coronary artery disease	3.76e-05	0.000147	CcSEcCtD
Capecitabine—Anorexia—Ramipril—coronary artery disease	3.76e-05	0.000147	CcSEcCtD
Capecitabine—Nausea—Ezetimibe—coronary artery disease	3.75e-05	0.000146	CcSEcCtD
Capecitabine—Skin disorder—Timolol—coronary artery disease	3.75e-05	0.000146	CcSEcCtD
Capecitabine—Dizziness—Olmesartan—coronary artery disease	3.75e-05	0.000146	CcSEcCtD
Capecitabine—Pruritus—Trandolapril—coronary artery disease	3.74e-05	0.000146	CcSEcCtD
Capecitabine—Arthralgia—Lisinopril—coronary artery disease	3.73e-05	0.000146	CcSEcCtD
Capecitabine—Chest pain—Lisinopril—coronary artery disease	3.73e-05	0.000146	CcSEcCtD
Capecitabine—Myalgia—Lisinopril—coronary artery disease	3.73e-05	0.000146	CcSEcCtD
Capecitabine—Hyperhidrosis—Timolol—coronary artery disease	3.73e-05	0.000146	CcSEcCtD
Capecitabine—Asthenia—Telmisartan—coronary artery disease	3.73e-05	0.000146	CcSEcCtD
Capecitabine—Pruritus—Enalapril—coronary artery disease	3.73e-05	0.000145	CcSEcCtD
Capecitabine—Diarrhoea—Pravastatin—coronary artery disease	3.73e-05	0.000145	CcSEcCtD
Capecitabine—Anxiety—Lisinopril—coronary artery disease	3.72e-05	0.000145	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.71e-05	0.000145	CcSEcCtD
Capecitabine—Discomfort—Lisinopril—coronary artery disease	3.69e-05	0.000144	CcSEcCtD
Capecitabine—Hypotension—Ramipril—coronary artery disease	3.69e-05	0.000144	CcSEcCtD
Capecitabine—Anorexia—Timolol—coronary artery disease	3.68e-05	0.000144	CcSEcCtD
Capecitabine—Pruritus—Telmisartan—coronary artery disease	3.68e-05	0.000144	CcSEcCtD
Capecitabine—Nausea—Eplerenone—coronary artery disease	3.67e-05	0.000143	CcSEcCtD
Capecitabine—Dizziness—Niacin—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Capecitabine—Urticaria—Losartan—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Capecitabine—Dry mouth—Lisinopril—coronary artery disease	3.65e-05	0.000143	CcSEcCtD
Capecitabine—Body temperature increased—Losartan—coronary artery disease	3.64e-05	0.000142	CcSEcCtD
Capecitabine—Abdominal pain—Losartan—coronary artery disease	3.64e-05	0.000142	CcSEcCtD
Capecitabine—Asthenia—Captopril—coronary artery disease	3.63e-05	0.000142	CcSEcCtD
Capecitabine—Diarrhoea—Trandolapril—coronary artery disease	3.62e-05	0.000141	CcSEcCtD
Capecitabine—Vomiting—Valsartan—coronary artery disease	3.62e-05	0.000141	CcSEcCtD
Capecitabine—Confusional state—Lisinopril—coronary artery disease	3.61e-05	0.000141	CcSEcCtD
Capecitabine—Diarrhoea—Enalapril—coronary artery disease	3.61e-05	0.000141	CcSEcCtD
Capecitabine—Hypotension—Timolol—coronary artery disease	3.61e-05	0.000141	CcSEcCtD
Capecitabine—Dizziness—Pravastatin—coronary artery disease	3.6e-05	0.000141	CcSEcCtD
Capecitabine—Vomiting—Olmesartan—coronary artery disease	3.6e-05	0.000141	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.6e-05	0.00014	CcSEcCtD
Capecitabine—Rash—Valsartan—coronary artery disease	3.59e-05	0.00014	CcSEcCtD
Capecitabine—Dermatitis—Valsartan—coronary artery disease	3.59e-05	0.00014	CcSEcCtD
Capecitabine—Nausea—Simvastatin—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Capecitabine—Oedema—Lisinopril—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Capecitabine—Pruritus—Captopril—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Capecitabine—Rash—Olmesartan—coronary artery disease	3.57e-05	0.000139	CcSEcCtD
Capecitabine—Insomnia—Ramipril—coronary artery disease	3.57e-05	0.000139	CcSEcCtD
Capecitabine—Dermatitis—Olmesartan—coronary artery disease	3.57e-05	0.000139	CcSEcCtD
Capecitabine—Headache—Valsartan—coronary artery disease	3.57e-05	0.000139	CcSEcCtD
Capecitabine—Diarrhoea—Telmisartan—coronary artery disease	3.56e-05	0.000139	CcSEcCtD
Capecitabine—Infection—Lisinopril—coronary artery disease	3.56e-05	0.000139	CcSEcCtD
Capecitabine—Headache—Olmesartan—coronary artery disease	3.55e-05	0.000138	CcSEcCtD
Capecitabine—Paraesthesia—Ramipril—coronary artery disease	3.54e-05	0.000138	CcSEcCtD
Capecitabine—Shock—Lisinopril—coronary artery disease	3.52e-05	0.000137	CcSEcCtD
Capecitabine—Asthenia—Perindopril—coronary artery disease	3.52e-05	0.000137	CcSEcCtD
Capecitabine—Dyspnoea—Ramipril—coronary artery disease	3.52e-05	0.000137	CcSEcCtD
Capecitabine—Vomiting—Niacin—coronary artery disease	3.52e-05	0.000137	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Timolol—coronary artery disease	3.52e-05	0.000137	CcSEcCtD
Capecitabine—Hypersensitivity—Furosemide—coronary artery disease	3.52e-05	0.000137	CcSEcCtD
Capecitabine—Thrombocytopenia—Lisinopril—coronary artery disease	3.5e-05	0.000137	CcSEcCtD
Capecitabine—Dizziness—Trandolapril—coronary artery disease	3.5e-05	0.000137	CcSEcCtD
Capecitabine—Tachycardia—Lisinopril—coronary artery disease	3.49e-05	0.000136	CcSEcCtD
Capecitabine—Insomnia—Timolol—coronary artery disease	3.49e-05	0.000136	CcSEcCtD
Capecitabine—Rash—Niacin—coronary artery disease	3.49e-05	0.000136	CcSEcCtD
Capecitabine—Dermatitis—Niacin—coronary artery disease	3.49e-05	0.000136	CcSEcCtD
Capecitabine—Dizziness—Enalapril—coronary artery disease	3.49e-05	0.000136	CcSEcCtD
Capecitabine—Skin disorder—Lisinopril—coronary artery disease	3.48e-05	0.000136	CcSEcCtD
Capecitabine—Dyspepsia—Ramipril—coronary artery disease	3.47e-05	0.000136	CcSEcCtD
Capecitabine—Pruritus—Perindopril—coronary artery disease	3.47e-05	0.000135	CcSEcCtD
Capecitabine—Headache—Niacin—coronary artery disease	3.47e-05	0.000135	CcSEcCtD
Capecitabine—Paraesthesia—Timolol—coronary artery disease	3.46e-05	0.000135	CcSEcCtD
Capecitabine—Vomiting—Pravastatin—coronary artery disease	3.46e-05	0.000135	CcSEcCtD
Capecitabine—Hyperhidrosis—Lisinopril—coronary artery disease	3.46e-05	0.000135	CcSEcCtD
Capecitabine—Diarrhoea—Captopril—coronary artery disease	3.46e-05	0.000135	CcSEcCtD
Capecitabine—Dyspnoea—Timolol—coronary artery disease	3.44e-05	0.000134	CcSEcCtD
Capecitabine—Dizziness—Telmisartan—coronary artery disease	3.44e-05	0.000134	CcSEcCtD
Capecitabine—Rash—Pravastatin—coronary artery disease	3.44e-05	0.000134	CcSEcCtD
Capecitabine—Dermatitis—Pravastatin—coronary artery disease	3.43e-05	0.000134	CcSEcCtD
Capecitabine—Decreased appetite—Ramipril—coronary artery disease	3.43e-05	0.000134	CcSEcCtD
Capecitabine—Asthenia—Furosemide—coronary artery disease	3.42e-05	0.000134	CcSEcCtD
Capecitabine—Headache—Pravastatin—coronary artery disease	3.41e-05	0.000133	CcSEcCtD
Capecitabine—Anorexia—Lisinopril—coronary artery disease	3.41e-05	0.000133	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Ramipril—coronary artery disease	3.41e-05	0.000133	CcSEcCtD
Capecitabine—Fatigue—Ramipril—coronary artery disease	3.4e-05	0.000133	CcSEcCtD
Capecitabine—Dyspepsia—Timolol—coronary artery disease	3.4e-05	0.000133	CcSEcCtD
Capecitabine—Hypersensitivity—Losartan—coronary artery disease	3.39e-05	0.000132	CcSEcCtD
Capecitabine—Nausea—Valsartan—coronary artery disease	3.38e-05	0.000132	CcSEcCtD
Capecitabine—Pruritus—Furosemide—coronary artery disease	3.38e-05	0.000132	CcSEcCtD
Capecitabine—Constipation—Ramipril—coronary artery disease	3.38e-05	0.000132	CcSEcCtD
Capecitabine—Nausea—Olmesartan—coronary artery disease	3.36e-05	0.000131	CcSEcCtD
Capecitabine—Vomiting—Trandolapril—coronary artery disease	3.36e-05	0.000131	CcSEcCtD
Capecitabine—Diarrhoea—Perindopril—coronary artery disease	3.36e-05	0.000131	CcSEcCtD
Capecitabine—Decreased appetite—Timolol—coronary artery disease	3.35e-05	0.000131	CcSEcCtD
Capecitabine—Vomiting—Enalapril—coronary artery disease	3.35e-05	0.000131	CcSEcCtD
Capecitabine—Hypotension—Lisinopril—coronary artery disease	3.34e-05	0.000131	CcSEcCtD
Capecitabine—Dizziness—Captopril—coronary artery disease	3.34e-05	0.00013	CcSEcCtD
Capecitabine—Rash—Trandolapril—coronary artery disease	3.34e-05	0.00013	CcSEcCtD
Capecitabine—Dermatitis—Trandolapril—coronary artery disease	3.33e-05	0.00013	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Timolol—coronary artery disease	3.33e-05	0.00013	CcSEcCtD
Capecitabine—Fatigue—Timolol—coronary artery disease	3.33e-05	0.00013	CcSEcCtD
Capecitabine—Rash—Enalapril—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Capecitabine—Dermatitis—Enalapril—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Capecitabine—Headache—Trandolapril—coronary artery disease	3.31e-05	0.000129	CcSEcCtD
Capecitabine—Vomiting—Telmisartan—coronary artery disease	3.31e-05	0.000129	CcSEcCtD
Capecitabine—Asthenia—Losartan—coronary artery disease	3.3e-05	0.000129	CcSEcCtD
Capecitabine—Headache—Enalapril—coronary artery disease	3.3e-05	0.000129	CcSEcCtD
Capecitabine—Pain—Timolol—coronary artery disease	3.3e-05	0.000129	CcSEcCtD
Capecitabine—Nausea—Niacin—coronary artery disease	3.29e-05	0.000128	CcSEcCtD
Capecitabine—Rash—Telmisartan—coronary artery disease	3.28e-05	0.000128	CcSEcCtD
Capecitabine—Dermatitis—Telmisartan—coronary artery disease	3.27e-05	0.000128	CcSEcCtD
Capecitabine—Diarrhoea—Furosemide—coronary artery disease	3.26e-05	0.000127	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.26e-05	0.000127	CcSEcCtD
Capecitabine—Pruritus—Losartan—coronary artery disease	3.26e-05	0.000127	CcSEcCtD
Capecitabine—Headache—Telmisartan—coronary artery disease	3.26e-05	0.000127	CcSEcCtD
Capecitabine—Feeling abnormal—Ramipril—coronary artery disease	3.25e-05	0.000127	CcSEcCtD
Capecitabine—Dizziness—Perindopril—coronary artery disease	3.25e-05	0.000127	CcSEcCtD
Capecitabine—Insomnia—Lisinopril—coronary artery disease	3.24e-05	0.000126	CcSEcCtD
Capecitabine—Nausea—Pravastatin—coronary artery disease	3.24e-05	0.000126	CcSEcCtD
Capecitabine—Gastrointestinal pain—Ramipril—coronary artery disease	3.23e-05	0.000126	CcSEcCtD
Capecitabine—Paraesthesia—Lisinopril—coronary artery disease	3.21e-05	0.000125	CcSEcCtD
Capecitabine—Vomiting—Captopril—coronary artery disease	3.21e-05	0.000125	CcSEcCtD
Capecitabine—Dyspnoea—Lisinopril—coronary artery disease	3.19e-05	0.000125	CcSEcCtD
Capecitabine—Rash—Captopril—coronary artery disease	3.19e-05	0.000124	CcSEcCtD
Capecitabine—Dermatitis—Captopril—coronary artery disease	3.18e-05	0.000124	CcSEcCtD
Capecitabine—Feeling abnormal—Timolol—coronary artery disease	3.18e-05	0.000124	CcSEcCtD
Capecitabine—Headache—Captopril—coronary artery disease	3.17e-05	0.000124	CcSEcCtD
Capecitabine—Gastrointestinal pain—Timolol—coronary artery disease	3.16e-05	0.000123	CcSEcCtD
Capecitabine—Dizziness—Furosemide—coronary artery disease	3.15e-05	0.000123	CcSEcCtD
Capecitabine—Dyspepsia—Lisinopril—coronary artery disease	3.15e-05	0.000123	CcSEcCtD
Capecitabine—Diarrhoea—Losartan—coronary artery disease	3.15e-05	0.000123	CcSEcCtD
Capecitabine—Nausea—Trandolapril—coronary artery disease	3.14e-05	0.000123	CcSEcCtD
Capecitabine—Urticaria—Ramipril—coronary artery disease	3.14e-05	0.000122	CcSEcCtD
Capecitabine—Nausea—Enalapril—coronary artery disease	3.13e-05	0.000122	CcSEcCtD
Capecitabine—Vomiting—Perindopril—coronary artery disease	3.12e-05	0.000122	CcSEcCtD
Capecitabine—Abdominal pain—Ramipril—coronary artery disease	3.12e-05	0.000122	CcSEcCtD
Capecitabine—Body temperature increased—Ramipril—coronary artery disease	3.12e-05	0.000122	CcSEcCtD
Capecitabine—Decreased appetite—Lisinopril—coronary artery disease	3.11e-05	0.000121	CcSEcCtD
Capecitabine—Rash—Perindopril—coronary artery disease	3.09e-05	0.000121	CcSEcCtD
Capecitabine—Dermatitis—Perindopril—coronary artery disease	3.09e-05	0.000121	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.09e-05	0.000121	CcSEcCtD
Capecitabine—Nausea—Telmisartan—coronary artery disease	3.09e-05	0.00012	CcSEcCtD
Capecitabine—Fatigue—Lisinopril—coronary artery disease	3.09e-05	0.00012	CcSEcCtD
Capecitabine—Headache—Perindopril—coronary artery disease	3.07e-05	0.00012	CcSEcCtD
Capecitabine—Urticaria—Timolol—coronary artery disease	3.07e-05	0.00012	CcSEcCtD
Capecitabine—Constipation—Lisinopril—coronary artery disease	3.06e-05	0.000119	CcSEcCtD
Capecitabine—Pain—Lisinopril—coronary artery disease	3.06e-05	0.000119	CcSEcCtD
Capecitabine—Body temperature increased—Timolol—coronary artery disease	3.05e-05	0.000119	CcSEcCtD
Capecitabine—Abdominal pain—Timolol—coronary artery disease	3.05e-05	0.000119	CcSEcCtD
Capecitabine—Dizziness—Losartan—coronary artery disease	3.04e-05	0.000119	CcSEcCtD
Capecitabine—Vomiting—Furosemide—coronary artery disease	3.03e-05	0.000118	CcSEcCtD
Capecitabine—Rash—Furosemide—coronary artery disease	3.01e-05	0.000117	CcSEcCtD
Capecitabine—Dermatitis—Furosemide—coronary artery disease	3.01e-05	0.000117	CcSEcCtD
Capecitabine—Nausea—Captopril—coronary artery disease	3e-05	0.000117	CcSEcCtD
Capecitabine—Headache—Furosemide—coronary artery disease	2.99e-05	0.000117	CcSEcCtD
Capecitabine—Feeling abnormal—Lisinopril—coronary artery disease	2.95e-05	0.000115	CcSEcCtD
Capecitabine—Gastrointestinal pain—Lisinopril—coronary artery disease	2.93e-05	0.000114	CcSEcCtD
Capecitabine—Vomiting—Losartan—coronary artery disease	2.93e-05	0.000114	CcSEcCtD
Capecitabine—Nausea—Perindopril—coronary artery disease	2.92e-05	0.000114	CcSEcCtD
Capecitabine—Hypersensitivity—Ramipril—coronary artery disease	2.91e-05	0.000113	CcSEcCtD
Capecitabine—Rash—Losartan—coronary artery disease	2.9e-05	0.000113	CcSEcCtD
Capecitabine—Dermatitis—Losartan—coronary artery disease	2.9e-05	0.000113	CcSEcCtD
Capecitabine—TYMS—Metabolism—ABCG5—coronary artery disease	2.89e-05	0.000269	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SULT1A1—coronary artery disease	2.89e-05	0.000269	CbGpPWpGaD
Capecitabine—Headache—Losartan—coronary artery disease	2.88e-05	0.000113	CcSEcCtD
Capecitabine—TYMS—Metabolism—HADHA—coronary artery disease	2.85e-05	0.000266	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAT—coronary artery disease	2.85e-05	0.000265	CbGpPWpGaD
Capecitabine—Urticaria—Lisinopril—coronary artery disease	2.84e-05	0.000111	CcSEcCtD
Capecitabine—Hypersensitivity—Timolol—coronary artery disease	2.84e-05	0.000111	CcSEcCtD
Capecitabine—Nausea—Furosemide—coronary artery disease	2.83e-05	0.000111	CcSEcCtD
Capecitabine—Asthenia—Ramipril—coronary artery disease	2.83e-05	0.000111	CcSEcCtD
Capecitabine—Body temperature increased—Lisinopril—coronary artery disease	2.83e-05	0.00011	CcSEcCtD
Capecitabine—Abdominal pain—Lisinopril—coronary artery disease	2.83e-05	0.00011	CcSEcCtD
Capecitabine—CDA—Metabolism—AGT—coronary artery disease	2.83e-05	0.000263	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA1—coronary artery disease	2.82e-05	0.000263	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	2.82e-05	0.000262	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GGT1—coronary artery disease	2.81e-05	0.000262	CbGpPWpGaD
Capecitabine—Pruritus—Ramipril—coronary artery disease	2.79e-05	0.000109	CcSEcCtD
Capecitabine—TYMS—Metabolism—LPA—coronary artery disease	2.79e-05	0.00026	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOE—coronary artery disease	2.77e-05	0.000258	CbGpPWpGaD
Capecitabine—Asthenia—Timolol—coronary artery disease	2.77e-05	0.000108	CcSEcCtD
Capecitabine—TYMP—Metabolism—APOB—coronary artery disease	2.77e-05	0.000258	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOA1—coronary artery disease	2.74e-05	0.000255	CbGpPWpGaD
Capecitabine—Nausea—Losartan—coronary artery disease	2.73e-05	0.000107	CcSEcCtD
Capecitabine—Pruritus—Timolol—coronary artery disease	2.73e-05	0.000107	CcSEcCtD
Capecitabine—DPYD—Metabolism—PPARG—coronary artery disease	2.71e-05	0.000252	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLCB3—coronary artery disease	2.7e-05	0.000251	CbGpPWpGaD
Capecitabine—Diarrhoea—Ramipril—coronary artery disease	2.7e-05	0.000105	CcSEcCtD
Capecitabine—TYMP—Metabolism—GSTM1—coronary artery disease	2.69e-05	0.000251	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA5—coronary artery disease	2.67e-05	0.000249	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—POMC—coronary artery disease	2.67e-05	0.000249	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LPL—coronary artery disease	2.64e-05	0.000246	CbGpPWpGaD
Capecitabine—Diarrhoea—Timolol—coronary artery disease	2.64e-05	0.000103	CcSEcCtD
Capecitabine—Hypersensitivity—Lisinopril—coronary artery disease	2.64e-05	0.000103	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN1—coronary artery disease	2.63e-05	0.000245	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—P4HB—coronary artery disease	2.62e-05	0.000244	CbGpPWpGaD
Capecitabine—Dizziness—Ramipril—coronary artery disease	2.61e-05	0.000102	CcSEcCtD
Capecitabine—TYMP—Metabolism—GPX1—coronary artery disease	2.58e-05	0.00024	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLA2G1B—coronary artery disease	2.57e-05	0.00024	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	2.57e-05	0.000239	CbGpPWpGaD
Capecitabine—Asthenia—Lisinopril—coronary artery disease	2.57e-05	0.0001	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CA5B—coronary artery disease	2.55e-05	0.000238	CbGpPWpGaD
Capecitabine—Dizziness—Timolol—coronary artery disease	2.55e-05	9.96e-05	CcSEcCtD
Capecitabine—Pruritus—Lisinopril—coronary artery disease	2.53e-05	9.88e-05	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—coronary artery disease	2.53e-05	0.000235	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CD36—coronary artery disease	2.51e-05	0.000234	CbGpPWpGaD
Capecitabine—Vomiting—Ramipril—coronary artery disease	2.51e-05	9.79e-05	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—coronary artery disease	2.49e-05	0.000232	CbGpPWpGaD
Capecitabine—Rash—Ramipril—coronary artery disease	2.49e-05	9.71e-05	CcSEcCtD
Capecitabine—Dermatitis—Ramipril—coronary artery disease	2.49e-05	9.7e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PPP2CA—coronary artery disease	2.48e-05	0.000231	CbGpPWpGaD
Capecitabine—Headache—Ramipril—coronary artery disease	2.47e-05	9.65e-05	CcSEcCtD
Capecitabine—Vomiting—Timolol—coronary artery disease	2.45e-05	9.57e-05	CcSEcCtD
Capecitabine—Diarrhoea—Lisinopril—coronary artery disease	2.45e-05	9.56e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—ALB—coronary artery disease	2.44e-05	0.000227	CbGpPWpGaD
Capecitabine—Rash—Timolol—coronary artery disease	2.43e-05	9.49e-05	CcSEcCtD
Capecitabine—Dermatitis—Timolol—coronary artery disease	2.43e-05	9.49e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—VCAN—coronary artery disease	2.43e-05	0.000226	CbGpPWpGaD
Capecitabine—Headache—Timolol—coronary artery disease	2.42e-05	9.43e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PPARG—coronary artery disease	2.41e-05	0.000225	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALDOA—coronary artery disease	2.41e-05	0.000224	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—coronary artery disease	2.38e-05	0.000222	CbGpPWpGaD
Capecitabine—CDA—Metabolism—POMC—coronary artery disease	2.38e-05	0.000222	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—coronary artery disease	2.38e-05	0.000222	CbGpPWpGaD
Capecitabine—Dizziness—Lisinopril—coronary artery disease	2.37e-05	9.24e-05	CcSEcCtD
Capecitabine—Nausea—Ramipril—coronary artery disease	2.34e-05	9.15e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—DCN—coronary artery disease	2.34e-05	0.000218	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NOS3—coronary artery disease	2.33e-05	0.000217	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—coronary artery disease	2.32e-05	0.000216	CbGpPWpGaD
Capecitabine—Nausea—Timolol—coronary artery disease	2.29e-05	8.94e-05	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—coronary artery disease	2.29e-05	0.000213	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	2.28e-05	0.000213	CbGpPWpGaD
Capecitabine—Vomiting—Lisinopril—coronary artery disease	2.28e-05	8.88e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ALDH2—coronary artery disease	2.27e-05	0.000212	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AGT—coronary artery disease	2.26e-05	0.000211	CbGpPWpGaD
Capecitabine—Rash—Lisinopril—coronary artery disease	2.26e-05	8.81e-05	CcSEcCtD
Capecitabine—Dermatitis—Lisinopril—coronary artery disease	2.25e-05	8.8e-05	CcSEcCtD
Capecitabine—Headache—Lisinopril—coronary artery disease	2.24e-05	8.75e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	2.24e-05	0.000208	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	2.24e-05	0.000208	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LIPC—coronary artery disease	2.22e-05	0.000206	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HBA1—coronary artery disease	2.22e-05	0.000206	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3C2A—coronary artery disease	2.22e-05	0.000206	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2C19—coronary artery disease	2.22e-05	0.000206	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOE—coronary artery disease	2.22e-05	0.000206	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOC3—coronary artery disease	2.2e-05	0.000205	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	2.2e-05	0.000205	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOA1—coronary artery disease	2.19e-05	0.000204	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LDLR—coronary artery disease	2.19e-05	0.000204	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—coronary artery disease	2.18e-05	0.000203	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CKMT1B—coronary artery disease	2.17e-05	0.000202	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—coronary artery disease	2.17e-05	0.000202	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTT1—coronary artery disease	2.16e-05	0.000201	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC9A1—coronary artery disease	2.16e-05	0.000201	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GCLC—coronary artery disease	2.14e-05	0.000199	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CETP—coronary artery disease	2.14e-05	0.000199	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS2—coronary artery disease	2.13e-05	0.000198	CbGpPWpGaD
Capecitabine—Nausea—Lisinopril—coronary artery disease	2.13e-05	8.3e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—SDC1—coronary artery disease	2.11e-05	0.000197	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	2.1e-05	0.000195	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NOS3—coronary artery disease	2.08e-05	0.000193	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	2.06e-05	0.000191	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	2.06e-05	0.000191	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSMA6—coronary artery disease	2e-05	0.000186	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSMB5—coronary artery disease	2e-05	0.000186	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	2e-05	0.000186	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	2e-05	0.000186	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CTGF—coronary artery disease	1.95e-05	0.000182	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMGCR—coronary artery disease	1.93e-05	0.00018	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GOT2—coronary artery disease	1.93e-05	0.00018	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—coronary artery disease	1.93e-05	0.00018	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—POMC—coronary artery disease	1.9e-05	0.000177	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—coronary artery disease	1.9e-05	0.000177	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	1.89e-05	0.000176	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	1.89e-05	0.000176	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	1.89e-05	0.000176	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	1.87e-05	0.000174	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	1.87e-05	0.000174	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	1.85e-05	0.000172	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—coronary artery disease	1.83e-05	0.00017	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	1.81e-05	0.000168	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLCB1—coronary artery disease	1.78e-05	0.000165	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UQCRFS1—coronary artery disease	1.77e-05	0.000165	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPAP2B—coronary artery disease	1.77e-05	0.000165	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CKM—coronary artery disease	1.77e-05	0.000165	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—coronary artery disease	1.74e-05	0.000162	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	1.73e-05	0.000161	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCA1—coronary artery disease	1.72e-05	0.00016	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	1.7e-05	0.000158	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GOT1—coronary artery disease	1.67e-05	0.000155	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GGT1—coronary artery disease	1.67e-05	0.000155	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	1.67e-05	0.000155	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NOS3—coronary artery disease	1.66e-05	0.000155	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PYGM—coronary artery disease	1.65e-05	0.000153	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PDK4—coronary artery disease	1.65e-05	0.000153	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SULT4A1—coronary artery disease	1.65e-05	0.000153	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CKMT2—coronary artery disease	1.65e-05	0.000153	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDH6A1—coronary artery disease	1.65e-05	0.000153	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—POMC—coronary artery disease	1.64e-05	0.000153	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—coronary artery disease	1.63e-05	0.000152	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS2—coronary artery disease	1.52e-05	0.000141	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTP1—coronary artery disease	1.5e-05	0.00014	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARGC1A—coronary artery disease	1.49e-05	0.000138	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMOX1—coronary artery disease	1.48e-05	0.000138	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMGCS2—coronary artery disease	1.47e-05	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GYG1—coronary artery disease	1.47e-05	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LDHA—coronary artery disease	1.47e-05	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GK—coronary artery disease	1.47e-05	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PFKM—coronary artery disease	1.47e-05	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GATM—coronary artery disease	1.47e-05	0.000137	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CAT—coronary artery disease	1.46e-05	0.000136	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	1.43e-05	0.000134	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	1.43e-05	0.000134	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	1.43e-05	0.000134	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK1—coronary artery disease	1.43e-05	0.000133	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	1.43e-05	0.000133	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	1.42e-05	0.000132	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOB—coronary artery disease	1.42e-05	0.000132	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCH1—coronary artery disease	1.4e-05	0.00013	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AK1—coronary artery disease	1.4e-05	0.00013	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	1.38e-05	0.000129	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—coronary artery disease	1.38e-05	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	1.37e-05	0.000127	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LPL—coronary artery disease	1.35e-05	0.000126	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MDH2—coronary artery disease	1.34e-05	0.000125	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UGCG—coronary artery disease	1.34e-05	0.000125	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLCD1—coronary artery disease	1.34e-05	0.000125	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPAT—coronary artery disease	1.34e-05	0.000125	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPX1—coronary artery disease	1.32e-05	0.000123	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—coronary artery disease	1.31e-05	0.000122	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PGM1—coronary artery disease	1.29e-05	0.00012	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CD36—coronary artery disease	1.28e-05	0.00012	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK1—coronary artery disease	1.28e-05	0.000119	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPP2CA—coronary artery disease	1.27e-05	0.000118	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.26e-05	0.000118	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.25e-05	0.000116	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PYGB—coronary artery disease	1.25e-05	0.000116	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CKB—coronary artery disease	1.25e-05	0.000116	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—coronary artery disease	1.22e-05	0.000113	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—DLAT—coronary artery disease	1.17e-05	0.000109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PFKFB3—coronary artery disease	1.17e-05	0.000109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—COX5B—coronary artery disease	1.17e-05	0.000109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM2—coronary artery disease	1.17e-05	0.000109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLIN1—coronary artery disease	1.17e-05	0.000109	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—coronary artery disease	1.17e-05	0.000109	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AGT—coronary artery disease	1.16e-05	0.000108	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOE—coronary artery disease	1.13e-05	0.000106	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA1—coronary artery disease	1.12e-05	0.000104	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.12e-05	0.000104	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SULT1E1—coronary artery disease	1.11e-05	0.000104	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.08e-05	0.000101	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—coronary artery disease	1.07e-05	9.97e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKR1B1—coronary artery disease	1.06e-05	9.88e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HK2—coronary artery disease	1.06e-05	9.88e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC27A1—coronary artery disease	1.02e-05	9.47e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CPT1B—coronary artery disease	9.97e-06	9.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LCAT—coronary artery disease	9.97e-06	9.28e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARG—coronary artery disease	9.87e-06	9.19e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA4—coronary artery disease	9.79e-06	9.11e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—POMC—coronary artery disease	9.74e-06	9.06e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	9.61e-06	8.95e-05	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—coronary artery disease	9.54e-06	8.88e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCLM—coronary artery disease	9.45e-06	8.8e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PDHA1—coronary artery disease	9.45e-06	8.8e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CA—coronary artery disease	9.34e-06	8.69e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	9.16e-06	8.53e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP11B2—coronary artery disease	9.16e-06	8.52e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TXNRD1—coronary artery disease	9.16e-06	8.52e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC22A3—coronary artery disease	9.02e-06	8.4e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ARNTL—coronary artery disease	8.89e-06	8.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HADH—coronary artery disease	8.89e-06	8.28e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—coronary artery disease	8.88e-06	8.26e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	8.75e-06	8.15e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	8.54e-06	7.95e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NOS3—coronary artery disease	8.49e-06	7.9e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	8.43e-06	7.85e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA2—coronary artery disease	8.43e-06	7.85e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX2—coronary artery disease	8.43e-06	7.85e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SULT1A1—coronary artery disease	8.32e-06	7.75e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCG5—coronary artery disease	8.32e-06	7.75e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX4—coronary artery disease	8.32e-06	7.75e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HK1—coronary artery disease	8.32e-06	7.75e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.31e-06	7.74e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HADHA—coronary artery disease	8.22e-06	7.66e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA1—coronary artery disease	8.13e-06	7.57e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LPA—coronary artery disease	8.04e-06	7.48e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLCB3—coronary artery disease	7.79e-06	7.25e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—coronary artery disease	7.77e-06	7.23e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA5—coronary artery disease	7.71e-06	7.18e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—coronary artery disease	7.63e-06	7.1e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—P4HB—coronary artery disease	7.56e-06	7.04e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.49e-06	6.97e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	7.42e-06	6.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.34e-06	6.83e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.25e-06	6.75e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—VCAN—coronary artery disease	6.99e-06	6.51e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDOA—coronary artery disease	6.94e-06	6.46e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—DCN—coronary artery disease	6.74e-06	6.27e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDH2—coronary artery disease	6.55e-06	6.1e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.39e-06	5.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HBA1—coronary artery disease	6.39e-06	5.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LIPC—coronary artery disease	6.39e-06	5.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2C19—coronary artery disease	6.39e-06	5.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	6.39e-06	5.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOC3—coronary artery disease	6.35e-06	5.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LDLR—coronary artery disease	6.31e-06	5.87e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.3e-06	5.87e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC9A1—coronary artery disease	6.23e-06	5.8e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTT1—coronary artery disease	6.23e-06	5.8e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCLC—coronary artery disease	6.16e-06	5.74e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CETP—coronary artery disease	6.16e-06	5.74e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SDC1—coronary artery disease	6.09e-06	5.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMB5—coronary artery disease	5.76e-06	5.36e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMA6—coronary artery disease	5.76e-06	5.36e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.74e-06	5.35e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CTGF—coronary artery disease	5.62e-06	5.23e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMGCR—coronary artery disease	5.57e-06	5.19e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GOT2—coronary artery disease	5.57e-06	5.19e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLCB1—coronary artery disease	5.12e-06	4.77e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.03e-06	4.68e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.97e-06	4.62e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GOT1—coronary artery disease	4.81e-06	4.48e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GGT1—coronary artery disease	4.81e-06	4.48e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—coronary artery disease	4.78e-06	4.45e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.32e-06	4.02e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.28e-06	3.99e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.26e-06	3.97e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAT—coronary artery disease	4.2e-06	3.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOB—coronary artery disease	4.08e-06	3.8e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.97e-06	3.7e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—coronary artery disease	3.9e-06	3.63e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LPL—coronary artery disease	3.9e-06	3.63e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX1—coronary artery disease	3.8e-06	3.54e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CD36—coronary artery disease	3.7e-06	3.45e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.66e-06	3.4e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.51e-06	3.27e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AGT—coronary artery disease	3.33e-06	3.1e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOE—coronary artery disease	3.27e-06	3.04e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA1—coronary artery disease	3.23e-06	3.01e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.09e-06	2.88e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—coronary artery disease	2.85e-06	2.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—POMC—coronary artery disease	2.81e-06	2.61e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—coronary artery disease	2.56e-06	2.38e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NOS3—coronary artery disease	2.45e-06	2.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.24e-06	2.08e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.38e-06	1.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—coronary artery disease	1.12e-06	1.05e-05	CbGpPWpGaD
